Mengo Children's Foundation US Incorporated
ICO
882215715
Web
Sign in to see organisation website
Address
Charleston
From Social media
News about from their social media (Facebook and X).
Data about organisation
Charleston
Organisations from Mengo Children's Foundation US Incorporated

1. Knights Templar of the United States of America
Can you hear us now.

Please remember to take the enchiladas out of the freezer.

3. ST MARK UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.

4. TRINITY (CHARLESTON) UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.

5. EPWORTH UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
Interesting nearby
Interesting organisations close by to residence of Mengo Children's Foundation US Incorporated

The Cooper School is a private, independent, non-sectarian K-8 school.

The South Carolina Aquarium inspires conservation of the natural world by exhibiting and caring for animals, by excelling in education and research, and by providing an exceptional visitor experience.

We are a non-profit organization founded in 2007.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

Exciting news! The Regional Teachers Initiative for Africa is seeking a Communications Assistant in Paris to help improve learning outcomes for children—making a positive impact across the continent! 🌍📚 #EducationForAll #PositiveChange
Communications Assistant (M/W) - Facility of the Regional Teachers Initiative for Africa (RTIA-Facility) in Paris - France
ReliefWeb
Like Comment
Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment